OBJECTIVES: Evaluation of a non-synonymous mutation associated with dihydropyrimidine dehydrogenase (DPD) deficiency. DESIGN AND METHODS: DPD enzyme analysis, mutation analysis and molecular dynamics simulations based on the 3D-model of DPD. RESULTS: The substitution Lys63Glu is likely to affect the FAD binding pocket within the DPD protein and contributes to a near-complete DPD deficiency in a patient with developmental retardation. CONCLUSIONS: Like other DPD variants attenuating FAD binding, Lys63Glu should be included in screening for DPD deficiency.
OBJECTIVES: Evaluation of a non-synonymous mutation associated with dihydropyrimidine dehydrogenase (DPD) deficiency. DESIGN AND METHODS: DPD enzyme analysis, mutation analysis and molecular dynamics simulations based on the 3D-model of DPD. RESULTS: The substitution Lys63Glu is likely to affect the FAD binding pocket within the DPD protein and contributes to a near-complete DPD deficiency in a patient with developmental retardation. CONCLUSIONS: Like other DPD variants attenuating FAD binding, Lys63Glu should be included in screening for DPD deficiency.
Authors: Reynold C Ly; Remington E Schmidt; Patrick J Kiel; Victoria M Pratt; Bryan P Schneider; Milan Radovich; Steven M Offer; Robert B Diasio; Todd C Skaar Journal: JCO Precis Oncol Date: 2020-06-12
Authors: Paula Soria-Chacartegui; Gonzalo Villapalos-García; Luis A López-Fernández; Marcos Navares-Gómez; Gina Mejía-Abril; Francisco Abad-Santos; Pablo Zubiaur Journal: Pharmaceutics Date: 2021-11-29 Impact factor: 6.321